Altogether, these findings demonstrate that low level of MAGI3 is significantly correlated with the poor prognosis of CRC patients, indicating that MAGI3 is a potential novel independent prognostic marker for CRC patients, and it may play important roles in CRC initiation and development. Here, MAGI3 is linked to colorectal carcinoma.